Skip to main content
. 2017 Nov 23;2017:7849851. doi: 10.1155/2017/7849851

Figure 2.

Figure 2

Several cell sources are being examined for use as an exosome therapy, most prominently cardiac progenitor cells, mesenchymal stem cells, and induced pluripotent stem cells as well as embryonic stem cells. Each of them has distinct advantages and disadvantages regarding cardiac regeneration.